Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut

Summary by The Health Standard
SUZHOU, China, Nov. 6, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced that the Company will present one…

31 Articles

Newsbug.infoNewsbug.info
+30 Reposted by 30 other sources
Center

ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut

SUZHOU, China, Nov. 6, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced that the Company will present one…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 89% of the sources are Center
89% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Friday, November 7, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Suzhou, China icon

Suzhou, China

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal